U.S. Household Products Stock News

The recent drop in Regions Financial (RF) stock was sparked by the Federal Reserve signaling no interest rate cuts in 2026. This stance pressured regional banks as investors reconsidered lending and margin expectations. See our latest analysis for Regions Financial. Beyond the immediate reaction to the Federal Reserve comments, Regions Financial’s share price has been under pressure in recent weeks. The 30 day share price return is down 5.23% and the 90 day share price return is down 10.36%...

Robert Half stock snapshot Robert Half (RHI) has drawn investor attention after recent trading left the stock around $25.12, with returns down about 8% over the past month but slightly higher over the past 3 months. See our latest analysis for Robert Half. Despite a 1-day share price gain of 1.78%, the stock has been under pressure, with a 7-day share price return down 7.07% and a 1-year total shareholder return down 43.54%. This signals fading momentum following a softer year-to-date share...

Community Financial System stock moves after recent performance trend Community Financial System (CBU) has been in focus after a mixed share performance, with the stock down over the past week, month, and past 3 months, but ahead over the past year and year to date. See our latest analysis for Community Financial System. At a share price of $61.72, Community Financial System has recently given up some ground, with short term share price returns weakening even as the year to date gain and 1...

Cabot stock at a glance Cabot (CBT) has drawn fresh attention after recent trading left the stock at US$81. For investors, that price sits alongside a reported US$3,575.0m in revenue and US$281.0m in net income. See our latest analysis for Cabot. Recent trading has been choppy, with the share price down over 1 day and over the past week. However, a 30-day share price return of 8.83% and a year-to-date share price return of 20.81% sit alongside a 1-year total shareholder return of 8.39%,...

nVent Electric (NVT) is back in focus after a series of company-specific developments, including record first quarter results, a new US$500 million share repurchase authorization, and confirmation of its regular cash dividend. See our latest analysis for nVent Electric. The stock has pulled back 2.85% on a 1-day share price basis to US$169.01 and is slightly lower over 7 days. However, the 30-day share price return of 25.48% and 1-year total shareholder return of 152.16% point to strong...

In early May 2026, TKO Group Holdings and the Arizona Sports & Events Alliance announced a three-year, seven-event agreement to host premier UFC, WWE, PBR and Zuffa Boxing events in Arizona, alongside TKO reporting first-quarter 2026 revenue of US$1,596.88 million and net income of US$89.35 million with reaffirmed full-year revenue guidance of US$5.68 billion to US$5.78 billion. Together, the Arizona live events deal and the latest quarterly results highlight how TKO is pairing content...

MoonLake Immunotherapeutics (MLTX) has cleared a key regulatory step by completing a final pre-BLA meeting with the FDA for sonelokimab in hidradenitis suppurativa, achieving alignment on efficacy, safety data inclusion, and submission timing. See our latest analysis for MoonLake Immunotherapeutics. Despite the recent pullback, with a 1-day share price return of 4.57% and a 30-day share price return of 4.31% both declining, MoonLake’s share price is still up 46.86% year to date, while the...

Setting the stage: what National Bank Holdings stock offers today National Bank Holdings (NBHC) has been drawing attention as investors reassess regional bank stocks, with its US$40.81 share price and recent returns giving a compact snapshot of how the stock has traded recently. See our latest analysis for National Bank Holdings. The recent pullback, with a 7 day share price return of -4.76% and a 30 day share price return of -3.70%, contrasts with a positive year to date share price return...

In the past quarter, Carrier Global reported Q1 2026 sales of US$5.3 billion and a 35% jump in global Commercial HVAC orders, powered by a very large increase in data center demand and new investments in AI-focused cooling technologies. At the same time, Carrier Ventures’ backing of advanced liquid cooling provider ZutaCore underlines how the company is tying its growth in data center orders to next‑generation infrastructure for high‑density AI workloads. Next, we’ll examine how this surge...

Why Hinge Health (HNGE) is on investors’ radar now Hinge Health (HNGE) has drawn fresh attention after a strong move in its share price over the past month, prompting investors to look more closely at its digital musculoskeletal care business and financial profile. See our latest analysis for Hinge Health. Recent trading has been choppy, with a 1-day share price return of 1.15% and a 7-day share price return down 2.71%. However, the 30-day and 90-day share price returns of 31.42% and 39.96%...

Earlier in May 2026, UroGen Pharma reported that UGN-103 achieved a 94.5% six-month durability of response in Phase 3 UTOPIA, while updated Phase 3 ENVISION data showed long-term response durability for ZUSDURI in recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. Together, these results highlight the potential for UroGen’s RTGel-based therapies to offer a non-surgical, chemoablative option that may reduce reliance on repeated bladder tumor resections for a large,...

In early May 2026, TransMedics Group reported first-quarter 2026 results showing revenue of US$173.93 million, up from US$143.54 million a year earlier, but net income fell to US$7.32 million from US$25.68 million and diluted earnings per share from continuing operations declined to US$0.20 from US$0.70. The company also reiterated its full-year 2026 revenue guidance of US$727 million to US$757 million, signaling confidence in continued top-line expansion even as profitability compressed in...

Arena One and AMC Theatres recently launched “Arena One at AMC,” a nationwide, real-time interactive concert format bringing artists like Bebe Rexha, Paris Hilton, Kim Petras, and Maren Morris to more than 300 U.S. locations, while AMC also reported first-quarter 2026 revenue of US$1.05 billion and a reduced net loss of US$117.1 million. This combination of an immersive live-concert product and year-on-year improvement in quarterly results highlights AMC’s efforts to broaden content...

Earlier this month, Cheniere Energy Partners, L.P. reported first-quarter 2026 results showing revenue of US$3.60 billion versus US$2.99 billion a year earlier, while net income fell to US$186 million from US$641 million and earnings per unit eased to US$0.19 from US$1.08. The partnership also reaffirmed its full-year 2026 distribution guidance of US$3.10–US$3.40 per common unit, underscoring its intention to maintain a US$3.10 base payout despite weaker quarterly profitability. Next, we’ll...

In May 2026, Prestige Consumer Healthcare reported fourth-quarter sales of US$281.62 million, down from US$296.52 million a year earlier, while net income and diluted EPS from continuing operations rose modestly. The earnings shortfall versus prior projections, combined with the previously undisclosed US$150 million LaCorium Health acquisition and ensuing legal scrutiny, has raised fresh concerns about the company’s transparency and operational execution. We’ll now examine how the earnings...

Hess Midstream LP recently reported past first-quarter 2026 results, posting higher year-over-year revenue of US$390.1 million and net income of US$87.6 million, alongside steady operational throughput across most segments. The company also reaffirmed its full-year 2026 net income outlook of US$650 million to US$700 million, signalling confidence in its fee-based midstream model despite mixed volume trends in crude and water gathering. Next, we will examine how reaffirmed 2026 earnings...

Earlier this month, Stifel Financial Corp. launched a Project Finance platform aimed at funding energy and infrastructure projects using proven commercial technologies, offering development loans, construction-to-term loans, interest rate swaps, depository services, and investment banking advisory support. This expansion builds on Stifel’s newer Energy Tech and Deep Tech teams, signaling a broader push to serve the evolving global energy and infrastructure ecosystem through integrated...

Marten Transport stock moves after recent performance data Marten Transport (MRTN) has drawn fresh attention after recent performance data highlighted both its current valuation and its business mix across truckload, dedicated, and brokerage operations for temperature controlled freight. See our latest analysis for Marten Transport. Recent trading has been a mixed picture, with Marten Transport’s 30 day share price return of 12.87% and year to date share price return of 35.55% contrasting...

In May 2026, CorMedix Inc. reported first-quarter 2026 revenue of US$127.43 million and net income of US$38.6 million, and raised its full-year 2026 net revenue guidance to a range of US$325 million to US$345 million. The quarter also featured positive Phase III topline results for REZZAYO in prophylaxis and continued advancement of DefenCath and taurolidine/heparin programs, underscoring how CorMedix is tying commercial growth to late-stage pipeline progress. Next, we’ll explore how...

AAON (AAON) is back in focus after reporting first quarter 2026 results, with sales of US$496.94 million and net income of US$39.82 million, and raising its full year revenue and margin outlook. See our latest analysis for AAON. AAON’s recent earnings upgrade and record backlog have kept the spotlight on the stock. It is now at US$135.49 after a 46.32% 1 month share price return and a 212.35% 5 year total shareholder return, suggesting momentum has been building despite a pullback in the past...

In early May 2026, Turning Point Brands reported first-quarter sales of US$124.28 million, up from US$106.44 million a year earlier, while net income fell to US$11.67 million and diluted earnings per share from continuing operations declined to US$0.60. Alongside these results, the company raised its full-year 2026 Modern Oral gross and net sales guidance and affirmed a regular quarterly dividend of US$0.08 per share, highlighting the growing importance of Modern Oral products to its...

Earlier this month, Paymentus Holdings reported first-quarter 2026 results with revenue of US$358.44 million and net income of US$20.88 million, raised its full-year 2026 revenue guidance to US$1.43 billion–US$1.44 billion, and issued second-quarter revenue guidance of US$340 million–US$350 million. The company also introduced its patented Billeo™ and BillWallet® offerings and broader AI-native Service Commerce platform, aiming to turn bills and other transactional documents into...

Agios Pharmaceuticals has submitted a supplemental New Drug Application to the FDA seeking accelerated approval of its oral PK activator mitapivat for sickle cell disease, supported by Phase 2/3 RISE UP data and an agreed 52-week confirmatory trial focused on transfusion burden. An important angle for investors is that mitapivat’s filing, backed by extensive clinical data and a global confirmatory study, could further define Agios’s profile as a rare-disease company centered on red blood...

Wondering whether CorVel at US$57.11 is starting to look like value or still has risk priced in? This article walks through what the current market price may be implying. The stock is up 1.3% over the past month but has fallen 13.1% year to date and declined 49.8% over the past year. These moves can change how you think about both upside potential and downside risk. Recent attention around CorVel has focused on its role within the US healthcare sector and how investors are reassessing...